Biostate AI Raises $12M Series A to Train the ChatGPT of Molecular Medicine
Biostate AI, a molecular diagnostics startup combining next-generation RNA sequencing (RNAseq) with generative AI, announced today it has raised $12 million in a Series A funding round led by Accel. The round also saw participation from Gaingels, Mana Ventures, InfoEdge Ventures, and returning investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. High-profile angels…